The presentation discusses the importance of Patient Information Leaflets (PILs) in medicine, which provide essential information on safe usage, dosage, side effects, and precautions for patients. It emphasizes the need for clear, accessible language to ensure patients understand the information, suggesting that complex terms be simplified and side effects categorized by seriousness. Key content components of PILs, including identification, therapeutic indications, and necessary information before use, are outlined.

1. Presentation
On
Patient Information Leaflet (PIL)
Amity University, NOIDA
Amity Institute of Pharmacy
By : Unnati Garg

2. DEFINITION
 Every medicine pack includes a patient information leaflet (PIL), which
provides information on using the medicine safely. PILs are based on the
Summaries of Product Characteristics (SPCs) which are a description of a
medicinal product's properties and the conditions attached to its use.
 It contains everything you need to know about your medicine. For example:
 what the medicine is intended for
 how you should use the medicine
 when you should not use the medicine
 when caution is advised
 which adverse events are possible
 which ingredients the medicine contains

3. Key Points
Complex language and
medical terms cause
difficulty in understanding
by patients
All the information should
be translated into lay-man
language.
Short sentences and/or
bullet points should be
used.
System organ class
arrangement should not
be used for side effects as
patients are unable to
follow the logic.
Side effects should be
grouped by seriousness to
enable patients to
understand when to take
action and what the
should be.

4. Guidelines before you start taking the
medicine
 Read all of this leaflet carefully.
 Keep this leaflet. You may need to read it again.
 If you have any further questions, ask your health care provider.
 This medicine has been prescribed for you. Do not pass it on to others. It
may harm them, even if their symptoms are the same as yours.
 If any of the side effects becomes serious, or if you notice any side effects
not listed in this leaflet, please tell your health care provider.

5. CONTENTS OF THE PIL

6. 1. Identification of the medicine
 The name of the medicine, the active substance(s), the pharmaceutical
form and the strength of the product should be stated.
2. Therapeutic Indications
 The conditions for which the medicine is authorized must be listed.
 The section should include any benefit information considered
appropriate.

7. 3. Information necessary before taking the
medicine
 Situations where the medicine should not be used , any precautions,
warnings, interactions with other medicines or foods, information for
special group of patients (pregnant or nursing mothers) and any effects
the medicine may have on the patient’s ability to drive.
4. Dosage
 How to take or use the medicine including both the route and method of
administration.
 How often it should be given.
 How long the course of treatment will last.

8. 5. Description of Side effects
 All the effects which may occur under normal use of the medicine and
what action the patient should take if any of these occur. They should be
listed by seriousness and then by frequency.
6. Additional Information
 This covers information on excipient detail, a description of the product,
registered pack sizes, storage conditions, name and address of the
manufacturer.

10. REFERENCES
 https://www.slideshare.net/sonushanno/patient-information-leaflets-29133935
 https://english.cbg-meb.nl/human/patients-and-consumers/patient-information-
leaflet